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Introduction
Approximately 90% of head and neck cancers are squa-
mous cell carcinomas [1, 2]. Squamous cell carcinomas 
(SCC) are the frequent malignant tumor of oral cavity, be-
ing responsible for a high number of cancer-related deaths 
worldwide [3]. In Western Europe, most head and neck 
squamous carcinomas (HNSCCs) have as etiological fac-
tors alcohol and tobacco (for oral cancers), but infection 
with high-risk human papilloma viruses (HPVs) is also 
now determined as an important etiological factor partic-
ularly for oropharynx [4-6]. According to the report pub-
lished by GLOBOCAN 2018 (global cancer statistics), more 
than 800000 new HNSCC cases are diagnosed each year. 
Currently, the majority of head and neck cancers are present 
with regionally advanced lymph node metastases at the time 
of diagnosis. The patients are often given the standard treat-
ment options of surgery, radiotherapy, chemotherapy, or a 
combination of these interventions, but 40–60% of treated 
patients experience recurrence and are irresponsive to sub-
sequent therapeutic interventions [7]. Therefore, despite 
the significant improvement in overall survival for patients 
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Abstract
Background: Head and neck squamous cell carcinomas (HNSCCs) are particularly aggressive epithelial tumors, that affect more than half a million 
patients worldwide each year. They represent a multi-factorial group of tumors caused by: alcohol, tobacco, and human papillomavirus (HPV) infections. 
Over the last ten years the overall 5-year survival rate of HNSCCs remained ~40–50%, inspite of significant improvement in clinical outcome of many 
tumor types. There are recent data that claim how some of these cells fulfill a suppressive role in the antitumor immune response. It is interesting that 
new clinical studies demonstrated that HPV (+) HNSCCs were among tumors with the highest immune infiltrates, while HPV (-) presented a reduced 
number of immune infiltrating cells.
Conclusions: Recent researches prove that tumor microenvironment of HNSCC has an important role in tumor progression, aggressivity, metastasis 
process, in addition to genetic aberrations and molecular alterations of cancer cells. New researches in stromal composition of the HNSCC may be useful 
in understanding of mechanisms of different responses to therapy, also can be used as a target for therapeutic purposes. Cancer-associated fibroblasts and 
immune cells, as well as their products found in neck squamous cell carcinoma significantly influence the biological properties of this tumor. Smoking 
is one of the risk factors of occurrence of most HPV-associated tumors. Promoting smoking cessation should become an essential contributor to the 
treatment of cancer in all oncologic pathologies. In cases when patients can’t quit smoking completely within the shortest possible period of time, doctors 
should focus on harm reduction strategies – tobacco harm reduction.
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with other tumor types, the 5-year rate of HNSCCs has not 
changed much over the past decade.
Discussion
The aim of this review is to present the role and effect 
of noncancerous cells and their crosstalks  with  cancer   
cells.  Furthermore  it  will  describe  the  metabolic  changes   
in tumor microenvir-onment, the new data about how some 
of these cells accomplish a suppressive role in the antitumor 
immune response. Finally, it will show the clinical signifi-
cance of all these factors according to the actual literature.
Overview on the tumor microenvironment (TME)
Head and neck squamous cell carcinoma is genetically 
a group of heterogeneous tumors. The tumor microenvi-
ronment represents an interactive, organized, and dynamic 
environment where cancerous cells as well as many differ-
ent cellular and biochemical structures exist together and 
are continuously in contact and interact with each other   
[8]. Squamous cell carcinomas microenvironment includes 
lymphocytes, macrophages, dendritic cells, vascular cells, 
and stromal cells.
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The cellular elements of the TME often develop abnor-
mal phenotypes in a spoil response to the cancer. Genetic 
changes in the carcinoma cells, like alterations of TP53, 
NOTCH1, and specific gene expression profiles, contribute 
to derangements in cancer and microenvironment cells in-
creased reactive oxygen species (ROS), overproduction of 
cytokines, and epithelial to mesenchymal transition [8].
Stromal Cell Contributions
Besides tumoral cells, miscellaneous stromal compo-
nents: cellular or acellular provide promoting and maintain-
ing of HNSCC invasion. Deposition of specific extracellular 
matrix (ECM) proteins (collagen IV, collagen XVII, fibro-
nectin, and laminin) is enhanced in HNSCC tumors and 
serves as a chemo-attractant for HNSCC cells in various in 
vitro invasion assays [9]. As HNSCC tumors progress to-
wards metastatic disease, non-tumor cell types from the as-
sociated stroma have been shown to have direct and indirect 
roles in facilitating HNSCC invasion [10].
1. Mast cells are part of the immune myeloid line, that 
mediate immune responses by granule exocyctosis, releas-
ing  histamine, serine proteases, carboxypeptidase A, pro-
teoglycans, prostaglandin D2, leukotriene C4, tumor necro-
sis factor (TNF)-α, IL-3, IL-4, IL-5, IL-6,  IL-8, and IL-16. 
In advanced stages of HNSCC, mast cells accumulate in the 
tumor stroma, and their presence is directly correlated with 
increased angiogenesis [11]. Additionally, heparanase, an 
enzyme involved in cleavage and remodeling heparin sul-
fate proteoglycans from the extracellular matrix, accumu-
lates at the HNSCC invasive front, and is a marker of poor 
prognosis for lymph node metastasis and tumor recurrence 
[12]. Mast cells, along with tumor infiltrating neutrophils, 
endothelial cells, and macrophages exhibit heparanase ac-
tivity [13]. Because, mast cells also secrete large amounts 
of heparin, they are the type of cells that probably are in 
charge for invasion-associated heparanase activity in the 
tumor microenvironment. Their presences also stimulate 
HNSCC tumor neo-vascularization and dissemination to 
loco-regional lymph nodes.
2. neutrophils are enlisted to the tumor microenviron-
ment by pro-inflammatory signals, including IL-8, trans-
forming growth factor (TGF)-β, IL-4, IL-10, IL-13 and 
TNF-α [14]. In tumor microenvironment, neutrophils se-
crete VEGF-A, stimulating neovascularization through en-
dothelial cell recruitment and proliferation, which can be 
suppressed by anti-VEGF-A antibodies or angiostatin treat-
ment [13, 14]. Also, neutrophil-derived HGF and MMP-9 
facilitate tumor cell migration and invasion towards the 
newly formed vascular bed [14].
3. Macrophages play a direct role in immune supervi-
sion via endocytosis of pathogens and cellular debris [15]. 
Infiltration into the tumor microenvironment with tumor 
associated macrophage (TAM) relates to lymph node in-
volvement, tumor stage, and extracapsular spread [16]. 
Once they arrive in the tumor microenvironment, they se-
cret several paracrine signaling loops that drive tumor cell 
invasion and metastasis. Macrophages are able to stimulate 
and maintain the HNSCC invasive phenotype, serve to 
basement membrane breakdown and recruitment of other 
cell types into the tumor microenvironment.
4. Fibroblasts are involved in demoplastic respons in 
cancer, as they can break and modify a variety of ECM pro-
teins including type I and IV collagens, laminin, and fibro-
nectin [17, 18]. Some studies suggest that HNSCC stroma is 
enriched in infiltrating cancer-associated fibroblasts (CAFs) 
and their highest concentration is near the invasive front 
of the tumor. CAFs have some characteristics of myofibro-
blasts, like enhanced proliferation, motility and secretion of 
matrix metalloproteinase-2 and hepatocyte growth factor 
(HGF). They express cytokeratins, vimentin, and α-smooth 
muscle actin (SMA) [19, 20]. Secretion of matrix metal-
loproteinase leads to extracellular matrix degradation and 
remodeling, while HGF enhances HNSCC cell motility [9, 
17, 21]. The final result of fibroblasts in the tumor microen-
vironment is permutation of extracellular matrix proteins, 
allowing fibroblasts to lead tumor cells into surrounding tis-
sues or creates pathways in the stroma for invasive tumor 
cells which result in HNSCC metastatic progression [22].
Involvement of HPV Virus in Head and neck cancers
A lot of studies relate that human papillomaviruses 
(HPVs) is implicated in the pathogenesis of HNSCCs. 
HPV16 represent a high-risk is the predominant HPV 
type in some forms of head and neck cancers, and it ac-
count about 90% of HPV DNA-positive tumors detected 
[22]. While, excessive smoking and alcohol usage represent 
major risk factors for the majority HPV (-) HNSCCs cases.
HnC and Tobacco use, Harm Reduction Strategies
Head and neck cancers are a heterogeneous group of tu-
mors, responsible for more than 650000 cases and 330000 
deaths per year worldwide, and one of the most important 
etiological factors is tobacco smoking [23]. The first con-
tact organ for tobacco smoke is mucosal tissue of the upper 
respiratory tract and the upper part of the digestive tract. 
Smoke contains chemical compounds, cytotoxic to the up-
per airway tissue, and can cause significant DNA damage. 
Therefore,the mutagenicity of tobacco smoke cannot be 
completely excluded as a risk factor for HNC [24]. Tobacco 
smoke is composed of over 7000 chemicals, of which at least 
69 are cancer-causing [25]. The biggest misconception is 
policymakers and community in general believes that nic-
otine is the cancer-causing culprit in cigarettes. Cigarette 
smoking and the many chemicals it exposes a person to, not 
nicotine itself, present the highest risk.
According to Cancer Research UK [26], nicotine is ad-
dictive but does not cause cancer. Most damage to health 
caused by smoking is due to other chemicals in smoke, such 
as benzo[a]pyrene, tobacco-specific nitrosamines, and ben-
zene, which are the primary causes of smoking-related dis-
eases [27]. The risk of developing cancer is always higher for 
tobacco smokers than for non-smokers. Electronic nicotine 
delivery system such as tobacco heating system (THS) for 
our country has become increasingly popular in the last 3 
years and is considered less harmful than traditional tobac-
co products, due to the lower content of toxic and carcino-
genic compounds [28].
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THS – uses an electronically controlled mechanism to 
precisely heat specially designed tobacco sticks at operating 
temperatures well below combustion (less than 350°C). As 
a result, the generated aerosol is composed of mainly wa-
ter, glycerin and nicotine while the levels of harmful and 
potentially harmful constituents are significantly decreased 
compared to cigarettes smoke [28, 29].
The Netherlands Institute of RIVM identified carcinoge-
nicity impact of switching from smoking cigarettes to con-
suming heated tobacco, the risk of cancer was reduced by 
10 to 20 times, depending on different types of cancer [30].
Harm Reduction as a solution for adult smokers
Harm reduction refers to a range of practical strategies 
aimed at lessening the negative social and physical conse-
quences associated with particularly risky human behav-
iors. Harm reduction policies are supported by 84 countries 
worldwide, with 74 countries having explicit supportive 
reference to harm reduction in national policy documents.
Quitting smoking is one of the most effective public 
health measures and tobacco harm reduction can supple-
ment tobacco control. Tobacco harm reduction remains a 
controversial topic in tobacco control. Tobacco harm re-
duction involves providing tobacco users who are unwilling 
or unable to quit using nicotine products with less harm-
ful nicotine containing products for continued use. Some 
Public Health experts believe that these products have great 
potential to reduce mortality and morbidity among smokers 
who completely switch to them. Others believe that we will 
be addicting another generation to tobacco products [31].
Researchers investigate the tumor-stroma interplay 
in high-risk human papilloma virus positive HPV+ and 
HPV- head and neck cancers from patients diagnosed with 
HNSCC. Immunosuppression in HPV positive HNSCC, 
is significant increased by viral infection, which may ex-
plain why, these tumors for the most part develop within 
the immune tissue of tonsillar lymphoid follicles,  an  ana-
tomic  site  that  should  favor  immunologic  antitumor  re-
sponse [32]. The immunosuppression produced by inflam-
matory cytokines maintains latent infection and favors 
tumor genesis, which is initiated when the viral DNA inte-
grates into the host genome and drives genomic instability. 
Once infected and transformed by HPV, tumor cells acti-
vate additional mechanisms to escape the immune system 
by preventing exposure of tumor antigens and promoting 
apoptosis of effector T lymphocytes and down-regulation of 
NK cells [4]. New knowledge in immunological character-
istics of HPV+ and HPV- HNSCCs may improve therapeutic 
targeting and immunotherapy strategies for different sub-
types of HNSCCs.
Conclusions
Recent research proves that tumor microenvironment 
of HNSCC has an important role in tumor progression, ag-
gressivity, metastasis process, in addition to genetic aber-
rations and molecular alterations of cancer cells. New re-
searches in stromal composition of the HNSCC may be use-
ful in understanding of mechanisms for different responses 
to therapy, also can be used as a targeted for therapeutic 
purposes. Cancer-associated fibroblasts and immune cells, 
as well as their products found in neck squamous cell car-
cinoma significantly influence the biological properties of 
this tumor. Smoking is one of the risk factors of occurrence 
of most HPV-associated tumors. Promoting smoking ces-
sation should become an essential contributor to the treat-
ment of cancer in all oncologic pathologies. In cases when 
patients can’t quit smoking completely within the shortest 
possible period of time, doctors should focus on harm re-
duction strategies – tobacco harm reduction.
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